Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beinaglutide Injection plus metformin vs metformin alone in overweight/obese PCOS patients undergoing IVF/ICSI
ChiCTR2500099523Phase 4Not yet recruiting
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Mar 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in polycystic ovary syndrome (PCOS) and female infertility comparing Metformin monotherapy (control group) with Beinaglutide plus metformin (treatment group) (2 arms). Primary endpoint: Clinical pregnancy rate. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
beinaglutidemetformin
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on ChiCTR2500099523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099523.